Global Iron Dextran Injection Market Growth 2025-2031

Publication ID:

LPI04254982

Publication Date:

April 23, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Iron Dextran Injection market size is predicted to grow from US$ 5658 million in 2025 to US$ 7352 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
听are a number of听iron听formulations used to treat and prevent听iron deficiency听including听iron deficiency anemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淚ron Dextran Injection Industry Forecast鈥� looks at past sales and reviews total world Iron Dextran Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Iron Dextran Injection sales for 2025 through 2031. With Iron Dextran Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iron Dextran Injection industry.
This Insight Report provides a comprehensive analysis of the global Iron Dextran Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iron Dextran Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Iron Dextran Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iron Dextran Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iron Dextran Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Iron Dextran Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human Use
Veterinary
Segmentation by Application:
Hospital
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Solupharm
Xinbai Pharma
Tianrui Pharma
Swiss Parenterals
Acino Pharma
Bimeda
Dong Bang
Flagship Biotech
KIVI Pharm
Qilu Animal Health
Vetoquinol
Pharmacosmos A/S
Key Questions Addressed in this Report
What is the 10-year outlook for the global Iron Dextran Injection market?
What factors are driving Iron Dextran Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iron Dextran Injection market opportunities vary by end market size?
How does Iron Dextran Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iron Dextran Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Iron Dextran Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Iron Dextran Injection by Country/Region, 2020, 2024 & 2031
2.2 Iron Dextran Injection Segment by Type
2.2.1 Human Use
2.2.2 Veterinary
2.3 Iron Dextran Injection Sales by Type
2.3.1 Global Iron Dextran Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Iron Dextran Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Iron Dextran Injection Sale Price by Type (2020-2025)
2.4 Iron Dextran Injection Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Iron Dextran Injection Sales by Application
2.5.1 Global Iron Dextran Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Iron Dextran Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Iron Dextran Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Iron Dextran Injection Breakdown Data by Company
3.1.1 Global Iron Dextran Injection Annual Sales by Company (2020-2025)
3.1.2 Global Iron Dextran Injection Sales Market Share by Company (2020-2025)
3.2 Global Iron Dextran Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Iron Dextran Injection Revenue by Company (2020-2025)
3.2.2 Global Iron Dextran Injection Revenue Market Share by Company (2020-2025)
3.3 Global Iron Dextran Injection Sale Price by Company
3.4 Key Manufacturers Iron Dextran Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iron Dextran Injection Product Location Distribution
3.4.2 Players Iron Dextran Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Iron Dextran Injection by Geographic Region
4.1 World Historic Iron Dextran Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Iron Dextran Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Iron Dextran Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Iron Dextran Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Iron Dextran Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Iron Dextran Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Iron Dextran Injection Sales Growth
4.4 APAC Iron Dextran Injection Sales Growth
4.5 Europe Iron Dextran Injection Sales Growth
4.6 Middle East & Africa Iron Dextran Injection Sales Growth
5 Americas
5.1 Americas Iron Dextran Injection Sales by Country
5.1.1 Americas Iron Dextran Injection Sales by Country (2020-2025)
5.1.2 Americas Iron Dextran Injection Revenue by Country (2020-2025)
5.2 Americas Iron Dextran Injection Sales by Type (2020-2025)
5.3 Americas Iron Dextran Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iron Dextran Injection Sales by Region
6.1.1 APAC Iron Dextran Injection Sales by Region (2020-2025)
6.1.2 APAC Iron Dextran Injection Revenue by Region (2020-2025)
6.2 APAC Iron Dextran Injection Sales by Type (2020-2025)
6.3 APAC Iron Dextran Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Iron Dextran Injection by Country
7.1.1 Europe Iron Dextran Injection Sales by Country (2020-2025)
7.1.2 Europe Iron Dextran Injection Revenue by Country (2020-2025)
7.2 Europe Iron Dextran Injection Sales by Type (2020-2025)
7.3 Europe Iron Dextran Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Iron Dextran Injection by Country
8.1.1 Middle East & Africa Iron Dextran Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Iron Dextran Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Iron Dextran Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Iron Dextran Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iron Dextran Injection
10.3 Manufacturing Process Analysis of Iron Dextran Injection
10.4 Industry Chain Structure of Iron Dextran Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iron Dextran Injection Distributors
11.3 Iron Dextran Injection Customer
12 World Forecast Review for Iron Dextran Injection by Geographic Region
12.1 Global Iron Dextran Injection Market Size Forecast by Region
12.1.1 Global Iron Dextran Injection Forecast by Region (2026-2031)
12.1.2 Global Iron Dextran Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Iron Dextran Injection Forecast by Type (2026-2031)
12.7 Global Iron Dextran Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Solupharm
13.1.1 Solupharm Company Information
13.1.2 Solupharm Iron Dextran Injection Product Portfolios and Specifications
13.1.3 Solupharm Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Solupharm Main Business Overview
13.1.5 Solupharm Latest Developments
13.2 Xinbai Pharma
13.2.1 Xinbai Pharma Company Information
13.2.2 Xinbai Pharma Iron Dextran Injection Product Portfolios and Specifications
13.2.3 Xinbai Pharma Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Xinbai Pharma Main Business Overview
13.2.5 Xinbai Pharma Latest Developments
13.3 Tianrui Pharma
13.3.1 Tianrui Pharma Company Information
13.3.2 Tianrui Pharma Iron Dextran Injection Product Portfolios and Specifications
13.3.3 Tianrui Pharma Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Tianrui Pharma Main Business Overview
13.3.5 Tianrui Pharma Latest Developments
13.4 Swiss Parenterals
13.4.1 Swiss Parenterals Company Information
13.4.2 Swiss Parenterals Iron Dextran Injection Product Portfolios and Specifications
13.4.3 Swiss Parenterals Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Swiss Parenterals Main Business Overview
13.4.5 Swiss Parenterals Latest Developments
13.5 Acino Pharma
13.5.1 Acino Pharma Company Information
13.5.2 Acino Pharma Iron Dextran Injection Product Portfolios and Specifications
13.5.3 Acino Pharma Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Acino Pharma Main Business Overview
13.5.5 Acino Pharma Latest Developments
13.6 Bimeda
13.6.1 Bimeda Company Information
13.6.2 Bimeda Iron Dextran Injection Product Portfolios and Specifications
13.6.3 Bimeda Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bimeda Main Business Overview
13.6.5 Bimeda Latest Developments
13.7 Dong Bang
13.7.1 Dong Bang Company Information
13.7.2 Dong Bang Iron Dextran Injection Product Portfolios and Specifications
13.7.3 Dong Bang Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dong Bang Main Business Overview
13.7.5 Dong Bang Latest Developments
13.8 Flagship Biotech
13.8.1 Flagship Biotech Company Information
13.8.2 Flagship Biotech Iron Dextran Injection Product Portfolios and Specifications
13.8.3 Flagship Biotech Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Flagship Biotech Main Business Overview
13.8.5 Flagship Biotech Latest Developments
13.9 KIVI Pharm
13.9.1 KIVI Pharm Company Information
13.9.2 KIVI Pharm Iron Dextran Injection Product Portfolios and Specifications
13.9.3 KIVI Pharm Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 KIVI Pharm Main Business Overview
13.9.5 KIVI Pharm Latest Developments
13.10 Qilu Animal Health
13.10.1 Qilu Animal Health Company Information
13.10.2 Qilu Animal Health Iron Dextran Injection Product Portfolios and Specifications
13.10.3 Qilu Animal Health Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Qilu Animal Health Main Business Overview
13.10.5 Qilu Animal Health Latest Developments
13.11 Vetoquinol
13.11.1 Vetoquinol Company Information
13.11.2 Vetoquinol Iron Dextran Injection Product Portfolios and Specifications
13.11.3 Vetoquinol Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vetoquinol Main Business Overview
13.11.5 Vetoquinol Latest Developments
13.12 Pharmacosmos A/S
13.12.1 Pharmacosmos A/S Company Information
13.12.2 Pharmacosmos A/S Iron Dextran Injection Product Portfolios and Specifications
13.12.3 Pharmacosmos A/S Iron Dextran Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Pharmacosmos A/S Main Business Overview
13.12.5 Pharmacosmos A/S Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂